Lexicon Pharmaceuticals Stock Price - LXRX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
After Hours
Last Trade
Last: $ 2.34 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Lexicon Pharmaceuticals Inc LXRX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.08 -3.31% 2.34 2.48 2.25 2.37 2.42 23:59:47
Bid Price Ask Price Spread Spread % News
2.12 2.48 0.36 14.52% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7,199 1,777,444 $ 2.40 $ 4,257,656 1,867,072 1.125 - 11.51
Last Trade Time Type Quantity Stock Price Currency
17:57:54 20 $ 2.41 USD

Lexicon Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 248.68M 106.27M $ -120.55M -1.14 - 104.27M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 11.00 1.90%

more financials information »

Lexicon Pharmaceuticals News

Date Time Source News Article
9/10/201916:54Dow Jones NewsLexicon Pharmaceuticals Says It Terminated Sanofi Alliance
9/10/201916:04Edgar (US Regulatory)Current Report Filing (8-k)
9/10/201916:01GlobeNewswire Inc.Lexicon Pharmaceuticals Announces Termination of Alliance..
8/30/201907:00GlobeNewswire Inc.Lexicon Pharmaceuticals To Present At Upcoming Investor..
8/20/201917:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
8/09/201907:00GlobeNewswire Inc.Lexicon Pharmaceuticals to Present at Upcoming Investor..
8/02/201916:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)

Latest LXRX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LXRX Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week1.32.711.292.12635M1.0480.00%
1 Month1.352.711.221.88632M0.9973.33%
3 Months5.966.721.1252.00632M-3.62-60.74%
6 Months7.698.551.1253.40871M-5.35-69.57%
1 Year10.811.511.1254.6266877k-8.46-78.33%
3 Years18.5619.621.1259.8789744k-16.22-87.39%
5 Years1.5219.620.88.0192922k0.8253.95%

Lexicon Pharmaceuticals Description

Lexicon Pharmaceuticals is a biopharmaceutical company that uses mouse genetics to discover the function of genes and find promising drug targets. Lexicon then designs and develops drugs for these targets, which cover a broad spectrum of therapeutic areas. Following a restructuring in January 2014, Lexicon focused efforts on two drugs: sotagliflozin in diabetes, which is partnered with Sanofi, and Xermelo (telotristat etiprate) in carcinoid syndrome, which is partnered with Ipsen outside the U.S. Early-stage programs include SGLT1 inhibitor LX2761 and neuropathic pain drug LX9211.
Your Recent History
NASDAQ
LXRX
Lexicon Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190915 09:45:37